_id
691857853c536f8df2317a4e
Ticker
0JAV.LSE
Name
Insmed Inc.
Exchange
LSE
Address
700 US Highway 202/206, Bridgewater, NJ, United States, 08807
Country
UK
Sector
Industry
Currency
USD
Website
https://www.insmed.com
Description
Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of refractory nontuberculous mycobacterial lung infections, as well as is in phase 3 clinical trial for the treatment of mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It also devlops brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1(DPP1) that is in phase 3 clinical trial for the treatment of bronchiectasis; and in phase 2 clinical trial for the treatment of chronic rhinosinusitis without nasal polyps and hidradenitis suppurativa. In addition, the company is developing treprostinil palmitil inhalation powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil, which is in phase 3 clinical trial for the treatment of pulmonary hypertension associated with interstitial lung disease; and phase 2 clinical trial for the treatment of pulmonary arterial hypertension. Further, it develops gene therapy, a microdystrophin adeno-associated virus gene replacement therapy which is in phase 1 clinical trial for the treatment of Duchenne muscular dystrophy, as well as is in pre-clinical development for gene therapy, next generation DPP1 inhibitor, deimmunized therapeutic protein, and synthetic rescue. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey.
Last Close
176
Volume
96
Current Price
177.37
Change
2.4702
Last Updated
2026-01-08T14:07:13.351Z
Image
https://logo.clearbit.com/www.insmed.com
Ipo Date
-
Market Cap
1593367859200
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
142342000
Cost Of Revenue
58730000
Gross Profit
83612000
Operating Expenses
508347000
Operating Income
-424735000
Interest Expense
20382000
Pretax Income
-368701000
Net Income
-370021000
Eps
-1.749996452911214
Dividends Per Share
-
Shares Outstanding
77090200
Income Tax Expense
1320000
EBITDA
-344323000
Operating Margin
-298.39049612904137
Total Other Income Expense Net
56034000
Cash
334764000
Short Term Investments
1345222000
Receivables
65259000
Inventories
120965000
Total Current Assets
1931807000
Property Plant Equipment
116618000
Total Assets
2360736000
Payables
79591000
Short Term Debt
12320000
Long Term Debt
-
Total Liabilities
1415165000
Equity
945571000
Bs_currency_symbol
-
Depreciation
3996000
Change In Working Capital
13896000
Cash From Operations
-219761000
Capital Expenditures
2418000
Cash From Investing
-762233000
Cash From Financing
33410000
Net Change In Cash
-949560000
Cf_currency_symbol
-
PE
-
PB
39.66205622845878
ROE
-39.13201652757963
ROA
-15.673967779539941
FCF
-222179000
Fcf Percent
-1.5608815388290174
Piotroski FScore
1
Health Score
17
Deep Value Investing Score
1.5
Defensive Investing Score
6
Dividend Investing Score
1.5
Economic Moat Investing Score
2.8
Garp Investing Score
3.5
Growth Investing Score
3
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
1.5
Value Investing Score
2
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
142342000
Quarters > 0 > income Statement > cost Of Revenue
58730000
Quarters > 0 > income Statement > gross Profit
83612000
Quarters > 0 > income Statement > operating Expenses
508347000
Quarters > 0 > income Statement > operating Income
-424735000
Quarters > 0 > income Statement > interest Expense
20382000
Quarters > 0 > income Statement > pretax Income
-368701000
Quarters > 0 > income Statement > net Income
-370021000
Quarters > 0 > income Statement > eps
-1.749996452911214
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
211441000
Quarters > 0 > income Statement > income Tax Expense
1320000
Quarters > 0 > income Statement > EBITDA
-344323000
Quarters > 0 > income Statement > operating Margin
-298.39049612904137
Quarters > 0 > income Statement > total Other Income Expense Net
56034000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
334764000
Quarters > 0 > balance Sheet > short Term Investments
1345222000
Quarters > 0 > balance Sheet > receivables
65259000
Quarters > 0 > balance Sheet > inventories
120965000
Quarters > 0 > balance Sheet > total Current Assets
1931807000
Quarters > 0 > balance Sheet > property Plant Equipment
116618000
Quarters > 0 > balance Sheet > total Assets
2360736000
Quarters > 0 > balance Sheet > payables
79591000
Quarters > 0 > balance Sheet > short Term Debt
12320000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1415165000
Quarters > 0 > balance Sheet > equity
945571000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-370021000
Quarters > 0 > cash Flow > depreciation
3996000
Quarters > 0 > cash Flow > change In Working Capital
13896000
Quarters > 0 > cash Flow > cash From Operations
-219761000
Quarters > 0 > cash Flow > capital Expenditures
2418000
Quarters > 0 > cash Flow > cash From Investing
-762233000
Quarters > 0 > cash Flow > cash From Financing
33410000
Quarters > 0 > cash Flow > net Change In Cash
-949560000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-1.749996452911214
Quarters > 0 > ratios > PB
39.66205622845878
Quarters > 0 > ratios > ROE
-39.13201652757963
Quarters > 0 > ratios > ROA
-15.673967779539941
Quarters > 0 > ratios > FCF
-222179000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-1.5608815388290174
Quarters > 0 > health Score
17
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
107415000
Quarters > 1 > income Statement > cost Of Revenue
28075000
Quarters > 1 > income Statement > gross Profit
79340000
Quarters > 1 > income Statement > operating Expenses
392216000
Quarters > 1 > income Statement > operating Income
-312876000
Quarters > 1 > income Statement > interest Expense
21245000
Quarters > 1 > income Statement > pretax Income
-320443000
Quarters > 1 > income Statement > net Income
-321686000
Quarters > 1 > income Statement > eps
-1.6993270012995108
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
189302000
Quarters > 1 > income Statement > income Tax Expense
1243000
Quarters > 1 > income Statement > EBITDA
-297127000
Quarters > 1 > income Statement > operating Margin
-291.27775450356097
Quarters > 1 > income Statement > total Other Income Expense Net
-7567000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
1284324000
Quarters > 1 > balance Sheet > short Term Investments
572441000
Quarters > 1 > balance Sheet > receivables
55033000
Quarters > 1 > balance Sheet > inventories
107605000
Quarters > 1 > balance Sheet > total Current Assets
2081580000
Quarters > 1 > balance Sheet > property Plant Equipment
117227000
Quarters > 1 > balance Sheet > total Assets
2479857000
Quarters > 1 > balance Sheet > payables
74054000
Quarters > 1 > balance Sheet > short Term Debt
10958000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1230122000
Quarters > 1 > balance Sheet > equity
1249735000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-321686000
Quarters > 1 > cash Flow > depreciation
3747000
Quarters > 1 > cash Flow > change In Working Capital
9538000
Quarters > 1 > cash Flow > cash From Operations
-205569000
Quarters > 1 > cash Flow > capital Expenditures
3484000
Quarters > 1 > cash Flow > cash From Investing
227835000
Quarters > 1 > cash Flow > cash From Financing
857806000
Quarters > 1 > cash Flow > net Change In Cash
881077000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-1.6993270012995108
Quarters > 1 > ratios > PB
26.866892373183116
Quarters > 1 > ratios > ROE
-25.740336951433708
Quarters > 1 > ratios > ROA
-12.97195765723588
Quarters > 1 > ratios > FCF
-209053000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-1.9462179397663268
Quarters > 1 > health Score
23
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
92823000
Quarters > 2 > income Statement > cost Of Revenue
21278000
Quarters > 2 > income Statement > gross Profit
71545000
Quarters > 2 > income Statement > operating Expenses
319685000
Quarters > 2 > income Statement > operating Income
-248140000
Quarters > 2 > income Statement > interest Expense
21569000
Quarters > 2 > income Statement > pretax Income
-255671000
Quarters > 2 > income Statement > net Income
-256583000
Quarters > 2 > income Statement > eps
-1.4186829591949575
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
180860000
Quarters > 2 > income Statement > income Tax Expense
912000
Quarters > 2 > income Statement > EBITDA
-232778000
Quarters > 2 > income Statement > operating Margin
-267.32598601639677
Quarters > 2 > income Statement > total Other Income Expense Net
-7531000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
403247000
Quarters > 2 > balance Sheet > short Term Investments
796204000
Quarters > 2 > balance Sheet > receivables
47746000
Quarters > 2 > balance Sheet > inventories
100713000
Quarters > 2 > balance Sheet > total Current Assets
1402692000
Quarters > 2 > balance Sheet > property Plant Equipment
116785000
Quarters > 2 > balance Sheet > total Assets
1802735000
Quarters > 2 > balance Sheet > payables
57683000
Quarters > 2 > balance Sheet > short Term Debt
10271000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1703576000
Quarters > 2 > balance Sheet > equity
99159000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-256583000
Quarters > 2 > cash Flow > depreciation
3146000
Quarters > 2 > cash Flow > change In Working Capital
-66090000
Quarters > 2 > cash Flow > cash From Operations
-262088000
Quarters > 2 > cash Flow > capital Expenditures
10070000
Quarters > 2 > cash Flow > cash From Investing
80412000
Quarters > 2 > cash Flow > cash From Financing
28998000
Quarters > 2 > cash Flow > net Change In Cash
-151783000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-1.4186829591949575
Quarters > 2 > ratios > PB
323.5121189201182
Quarters > 2 > ratios > ROE
-258.7591645740679
Quarters > 2 > ratios > ROA
-14.232984881305349
Quarters > 2 > ratios > FCF
-272158000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-2.9320103853570774
Quarters > 2 > health Score
8
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
104442000
Quarters > 3 > income Statement > cost Of Revenue
26151000
Quarters > 3 > income Statement > gross Profit
78291000
Quarters > 3 > income Statement > operating Expenses
308705000
Quarters > 3 > income Statement > operating Income
-230414000
Quarters > 3 > income Statement > interest Expense
21550000
Quarters > 3 > income Statement > pretax Income
-234282000
Quarters > 3 > income Statement > net Income
-235548000
Quarters > 3 > income Statement > eps
-1.3157562520598143
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
179021000
Quarters > 3 > income Statement > income Tax Expense
1266000
Quarters > 3 > income Statement > EBITDA
-211739000
Quarters > 3 > income Statement > operating Margin
-220.61431224986117
Quarters > 3 > income Statement > total Other Income Expense Net
-3868000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
555030000
Quarters > 3 > balance Sheet > short Term Investments
878796000
Quarters > 3 > balance Sheet > receivables
52012000
Quarters > 3 > balance Sheet > inventories
98578000
Quarters > 3 > balance Sheet > total Current Assets
1621661000
Quarters > 3 > balance Sheet > property Plant Equipment
115582000
Quarters > 3 > balance Sheet > total Assets
2025231000
Quarters > 3 > balance Sheet > payables
73033000
Quarters > 3 > balance Sheet > short Term Debt
16495999
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1739852000
Quarters > 3 > balance Sheet > equity
285379000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-235548000
Quarters > 3 > cash Flow > depreciation
2741000
Quarters > 3 > cash Flow > change In Working Capital
28122000
Quarters > 3 > cash Flow > cash From Operations
-195979000
Quarters > 3 > cash Flow > capital Expenditures
6772000
Quarters > 3 > cash Flow > cash From Investing
131758000
Quarters > 3 > cash Flow > cash From Financing
159305000
Quarters > 3 > cash Flow > net Change In Cash
93579000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-1.3157562520598143
Quarters > 3 > ratios > PB
111.26591224301718
Quarters > 3 > ratios > ROE
-82.53865911647318
Quarters > 3 > ratios > ROA
-11.630673241719093
Quarters > 3 > ratios > FCF
-202751000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-1.9412784128990253
Quarters > 3 > health Score
9
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
363707000
Annuals > 0 > income Statement > cost Of Revenue
85742000
Annuals > 0 > income Statement > gross Profit
277965000
Annuals > 0 > income Statement > operating Expenses
1156217000
Annuals > 0 > income Statement > operating Income
-878252000
Annuals > 0 > income Statement > interest Expense
84913000
Annuals > 0 > income Statement > pretax Income
-910065000
Annuals > 0 > income Statement > net Income
-913772000
Annuals > 0 > income Statement > eps
-5.570319977079181
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
164043000
Annuals > 0 > income Statement > income Tax Expense
3707000
Annuals > 0 > income Statement > EBITDA
-818794000
Annuals > 0 > income Statement > operating Margin
-241.47239398746794
Annuals > 0 > income Statement > total Other Income Expense Net
-31813000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
555030000
Annuals > 0 > balance Sheet > short Term Investments
878796000
Annuals > 0 > balance Sheet > receivables
52012000
Annuals > 0 > balance Sheet > inventories
98578000
Annuals > 0 > balance Sheet > total Current Assets
1621661000
Annuals > 0 > balance Sheet > property Plant Equipment
115582000
Annuals > 0 > balance Sheet > total Assets
2025231000
Annuals > 0 > balance Sheet > payables
73033000
Annuals > 0 > balance Sheet > short Term Debt
16495999
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1739852000
Annuals > 0 > balance Sheet > equity
285379000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-913772000
Annuals > 0 > cash Flow > depreciation
11013000
Annuals > 0 > cash Flow > change In Working Capital
-3177000
Annuals > 0 > cash Flow > cash From Operations
-683882000
Annuals > 0 > cash Flow > capital Expenditures
21923000
Annuals > 0 > cash Flow > cash From Investing
-583175000
Annuals > 0 > cash Flow > cash From Financing
1341020000
Annuals > 0 > cash Flow > net Change In Cash
72656000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-5.570319977079181
Annuals > 0 > ratios > PB
101.95672039638517
Annuals > 0 > ratios > ROE
-320.1959499472631
Annuals > 0 > ratios > ROA
-45.1193962565258
Annuals > 0 > ratios > FCF
-705805000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-1.9405867910158452
Annuals > 0 > health Score
8
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
305208000
Annuals > 1 > income Statement > cost Of Revenue
65573000
Annuals > 1 > income Statement > gross Profit
239635000
Annuals > 1 > income Statement > operating Expenses
949261000
Annuals > 1 > income Statement > operating Income
-709626000
Annuals > 1 > income Statement > interest Expense
81694000
Annuals > 1 > income Statement > pretax Income
-747012000
Annuals > 1 > income Statement > net Income
-749567000
Annuals > 1 > income Statement > eps
-5.337541745885939
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
140433000
Annuals > 1 > income Statement > income Tax Expense
2555000
Annuals > 1 > income Statement > EBITDA
-660177000
Annuals > 1 > income Statement > operating Margin
-232.50570103011717
Annuals > 1 > income Statement > total Other Income Expense Net
-37386000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
482374000
Annuals > 1 > balance Sheet > short Term Investments
298073000
Annuals > 1 > balance Sheet > receivables
41189000
Annuals > 1 > balance Sheet > inventories
83248000
Annuals > 1 > balance Sheet > total Current Assets
929063000
Annuals > 1 > balance Sheet > property Plant Equipment
104386000
Annuals > 1 > balance Sheet > total Assets
1329837000
Annuals > 1 > balance Sheet > payables
65393000
Annuals > 1 > balance Sheet > short Term Debt
10642000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1661760000
Annuals > 1 > balance Sheet > equity
-331923000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-749567000
Annuals > 1 > cash Flow > depreciation
10579000
Annuals > 1 > cash Flow > change In Working Capital
-39218000
Annuals > 1 > cash Flow > cash From Operations
-536247000
Annuals > 1 > cash Flow > capital Expenditures
13288000
Annuals > 1 > cash Flow > cash From Investing
-223604000
Annuals > 1 > cash Flow > cash From Financing
168439000
Annuals > 1 > cash Flow > net Change In Cash
-591662000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-5.337541745885939
Annuals > 1 > ratios > PB
-75.04331188257517
Annuals > 1 > ratios > ROE
225.82556797811543
Annuals > 1 > ratios > ROA
-56.36532898392811
Annuals > 1 > ratios > FCF
-549535000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-1.8005261985269063
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
245358000
Annuals > 2 > income Statement > cost Of Revenue
55126000
Annuals > 2 > income Statement > gross Profit
190232000
Annuals > 2 > income Statement > operating Expenses
647553000
Annuals > 2 > income Statement > operating Income
-457321000
Annuals > 2 > income Statement > interest Expense
26446000
Annuals > 2 > income Statement > pretax Income
-480151000
Annuals > 2 > income Statement > net Income
-481534000
Annuals > 2 > income Statement > eps
-3.9137968870646564
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
123035000
Annuals > 2 > income Statement > income Tax Expense
1383000
Annuals > 2 > income Statement > EBITDA
-447365000
Annuals > 2 > income Statement > operating Margin
-186.3892760782204
Annuals > 2 > income Statement > total Other Income Expense Net
-22830000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
1074036000
Annuals > 2 > balance Sheet > short Term Investments
74244000
Annuals > 2 > balance Sheet > receivables
29713000
Annuals > 2 > balance Sheet > inventories
69922000
Annuals > 2 > balance Sheet > total Current Assets
1273383000
Annuals > 2 > balance Sheet > property Plant Equipment
102082000
Annuals > 2 > balance Sheet > total Assets
1656435000
Annuals > 2 > balance Sheet > payables
50461000
Annuals > 2 > balance Sheet > short Term Debt
8126000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1568484000
Annuals > 2 > balance Sheet > equity
87951000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-481534000
Annuals > 2 > cash Flow > depreciation
10331000
Annuals > 2 > cash Flow > change In Working Capital
6575000
Annuals > 2 > cash Flow > cash From Operations
-400439000
Annuals > 2 > cash Flow > capital Expenditures
9878000
Annuals > 2 > cash Flow > cash From Investing
-34584000
Annuals > 2 > cash Flow > cash From Financing
793273000
Annuals > 2 > cash Flow > net Change In Cash
357254000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-3.9137968870646564
Annuals > 2 > ratios > PB
248.1235909767939
Annuals > 2 > ratios > ROE
-547.5025866675762
Annuals > 2 > ratios > ROA
-29.070503822969208
Annuals > 2 > ratios > FCF
-410317000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-1.6723196309066752
Annuals > 2 > health Score
8
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
188461000
Annuals > 3 > income Statement > cost Of Revenue
44152000
Annuals > 3 > income Statement > gross Profit
144309000
Annuals > 3 > income Statement > operating Expenses
519403000
Annuals > 3 > income Statement > operating Income
-375094000
Annuals > 3 > income Statement > interest Expense
40473000
Annuals > 3 > income Statement > pretax Income
-436412000
Annuals > 3 > income Statement > net Income
-434654000
Annuals > 3 > income Statement > eps
-3.876996904853226
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
112111000
Annuals > 3 > income Statement > income Tax Expense
-1758000
Annuals > 3 > income Statement > EBITDA
-383647000
Annuals > 3 > income Statement > operating Margin
-199.03003804500665
Annuals > 3 > income Statement > total Other Income Expense Net
-61318000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
716782000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
24351000
Annuals > 3 > balance Sheet > inventories
67009000
Annuals > 3 > balance Sheet > total Current Assets
837040000
Annuals > 3 > balance Sheet > property Plant Equipment
95516000
Annuals > 3 > balance Sheet > total Assets
1243508000
Annuals > 3 > balance Sheet > payables
35784000
Annuals > 3 > balance Sheet > short Term Debt
10136000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
833040000
Annuals > 3 > balance Sheet > equity
410468000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-434654000
Annuals > 3 > cash Flow > depreciation
14182000
Annuals > 3 > cash Flow > change In Working Capital
-58580000
Annuals > 3 > cash Flow > cash From Operations
-363302000
Annuals > 3 > cash Flow > capital Expenditures
7289000
Annuals > 3 > cash Flow > cash From Investing
-64285000
Annuals > 3 > cash Flow > cash From Financing
612546000
Annuals > 3 > cash Flow > net Change In Cash
184026000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-3.876996904853226
Annuals > 3 > ratios > PB
48.44501415457478
Annuals > 3 > ratios > ROE
-105.89229854702438
Annuals > 3 > ratios > ROA
-34.95385634833069
Annuals > 3 > ratios > FCF
-370591000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-1.966406842795061
Annuals > 3 > health Score
12
Valuation > metrics > PE
-1.749996452911214
Valuation > metrics > PB
39.66205622845878
Valuation > final Score
20
Valuation > verdict
1222.1% Overvalued
Profitability > metrics > ROE
-39.13201652757963
Profitability > metrics > ROA
-19.154139103958105
Profitability > metrics > Net Margin
-2.599520872265389
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.4966247907349104
Risk > metrics > Interest Coverage
-20.8387302521833
Risk > final Score
-53
Risk > verdict
High
Liquidity > metrics > Current Ratio
21.018235031715463
Liquidity > metrics > Quick Ratio
19.702124881679016
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-11
Prev Risks > 1
-40
Prev Risks > 2
-37
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:54:28.895Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-05-06
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-12-31
Earnings History > 1 > report Date
2026-02-19
Earnings History > 1 > date
2025-12-31
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-
Earnings History > 1 > eps Estimate
-1.36
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-09-30
Earnings History > 2 > report Date
2025-10-30
Earnings History > 2 > date
2025-09-30
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-1.7474
Earnings History > 2 > eps Estimate
-1.37
Earnings History > 2 > eps Difference
-0.3774
Earnings History > 2 > surprise Percent
-27.5474
Earnings History > 3 > period
2025-06-30
Earnings History > 3 > report Date
2025-08-07
Earnings History > 3 > date
2025-06-30
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-1.6993
Earnings History > 3 > eps Estimate
-1.31
Earnings History > 3 > eps Difference
-0.3893
Earnings History > 3 > surprise Percent
-29.7176
Earnings History > 4 > period
2025-03-31
Earnings History > 4 > report Date
2025-05-08
Earnings History > 4 > date
2025-03-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-1.4187
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-12-31
Earnings History > 5 > report Date
2025-02-20
Earnings History > 5 > date
2024-12-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-1.3158
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-09-30
Earnings History > 6 > report Date
2024-10-31
Earnings History > 6 > date
2024-09-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-1.2694
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-06-30
Earnings History > 7 > report Date
2024-08-08
Earnings History > 7 > date
2024-06-30
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-1.9431
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2024-03-31
Earnings History > 8 > report Date
2024-05-09
Earnings History > 8 > date
2024-03-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
-1.0582
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-12-31
Earnings History > 9 > report Date
2024-03-15
Earnings History > 9 > date
2023-12-31
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
-1.2849
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-09-30
Earnings History > 10 > report Date
2023-10-26
Earnings History > 10 > date
2023-09-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
-1.1122
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-06-30
Earnings History > 11 > report Date
2023-08-03
Earnings History > 11 > date
2023-06-30
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
-1.7797
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2023-03-31
Earnings History > 12 > report Date
2023-05-04
Earnings History > 12 > date
2023-03-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-1.1717
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-12-31
Earnings History > 13 > report Date
2023-02-23
Earnings History > 13 > date
2022-12-31
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-1.2067
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-09-30
Earnings History > 14 > report Date
2022-10-27
Earnings History > 14 > date
2022-09-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
-1.0857
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2022-06-30
Earnings History > 15 > report Date
2022-08-04
Earnings History > 15 > date
2022-06-30
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
-0.7997
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2022-03-31
Earnings History > 16 > report Date
2022-05-05
Earnings History > 16 > date
2022-03-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
-0.7956
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-12-31
Earnings History > 17 > report Date
2022-02-17
Earnings History > 17 > date
2021-12-31
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
-
Earnings History > 17 > eps Actual
-0.9534
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-09-30
Earnings History > 18 > report Date
2021-10-28
Earnings History > 18 > date
2021-09-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
-
Earnings History > 18 > eps Actual
-0.9626
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2021-06-30
Earnings History > 19 > report Date
2021-08-05
Earnings History > 19 > date
2021-06-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
-
Earnings History > 19 > eps Actual
-1.0706
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2021-03-31
Earnings History > 20 > report Date
2021-05-06
Earnings History > 20 > date
2021-03-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
-
Earnings History > 20 > eps Actual
-0.8894
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-12-31
Earnings History > 21 > report Date
2020-12-31
Earnings History > 21 > date
2020-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
-
Earnings History > 21 > eps Actual
-0.9992
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-09-30
Earnings History > 22 > report Date
2020-09-30
Earnings History > 22 > date
2020-09-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
-
Earnings History > 22 > eps Actual
-0.6265
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2020-06-30
Earnings History > 23 > report Date
2020-06-30
Earnings History > 23 > date
2020-06-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
-
Earnings History > 23 > eps Actual
-0.6401
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2020-03-31
Earnings History > 24 > report Date
2020-03-31
Earnings History > 24 > date
2020-03-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
-
Earnings History > 24 > eps Actual
-0.7392
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-12-31
Earnings History > 25 > report Date
2019-12-31
Earnings History > 25 > date
2019-12-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
-
Earnings History > 25 > eps Actual
-0.5923
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-09-30
Earnings History > 26 > report Date
2019-09-30
Earnings History > 26 > date
2019-09-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
-
Earnings History > 26 > eps Actual
-0.6799
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2019-06-30
Earnings History > 27 > report Date
2019-06-30
Earnings History > 27 > date
2019-06-30
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
-
Earnings History > 27 > eps Actual
-0.8131
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2019-03-31
Earnings History > 28 > report Date
2019-03-31
Earnings History > 28 > date
2019-03-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
-
Earnings History > 28 > eps Actual
-0.9563
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-12-31
Earnings History > 29 > report Date
2018-12-31
Earnings History > 29 > date
2018-12-31
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
-
Earnings History > 29 > eps Actual
-1.1878
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-09-30
Earnings History > 30 > report Date
2018-09-30
Earnings History > 30 > date
2018-09-30
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
-
Earnings History > 30 > eps Actual
-1.1385
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2018-06-30
Earnings History > 31 > report Date
2018-06-30
Earnings History > 31 > date
2018-06-30
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
-
Earnings History > 31 > eps Actual
-0.9957
Earnings History > 31 > eps Estimate
-
Earnings History > 31 > eps Difference
0
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2018-03-31
Earnings History > 32 > report Date
2018-03-31
Earnings History > 32 > date
2018-03-31
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
-
Earnings History > 32 > eps Actual
-0.8943
Earnings History > 32 > eps Estimate
-
Earnings History > 32 > eps Difference
0
Earnings History > 32 > surprise Percent
-
Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of refractory nontuberculous mycobacterial lung infections, as well as is in phase 3 clinical trial for the treatment of mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It also devlops brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1(DPP1) that is in phase 3 clinical trial for the treatment of bronchiectasis; and in phase 2 clinical trial for the treatment of chronic rhinosinusitis without nasal polyps and hidradenitis suppurativa. In addition, the company is developing treprostinil palmitil inhalation powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil, which is in phase 3 clinical trial for the treatment of pulmonary hypertension associated with interstitial lung disease; and phase 2 clinical trial for the treatment of pulmonary arterial hypertension. Further, it develops gene therapy, a microdystrophin adeno-associated virus gene replacement therapy which is in phase 1 clinical trial for the treatment of Duchenne muscular dystrophy, as well as is in pre-clinical development for gene therapy, next generation DPP1 inhibitor, deimmunized therapeutic protein, and synthetic rescue. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Insmed Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-1.36
Date
2025-09-30
EPS Actual
-1.7474
EPS Estimate
-1.37
EPS Difference
-0.3774
Surprise Percent
-27.5474%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.